Skip to main content
All

The Legal 500 Greater China 2027 Recognizes Arnold & Porter’s International Arbitration and Life Sciences Capabilities

November 19, 2026

The 2027 edition of The Legal 500 Greater China recognized Arnold & Porter’s International Arbitration and Life Sciences & Healthcare practices. The Legal 500 researches the global legal market using feedback from 300,000 in-house counsel and lawyers worldwide.

The guide highlighted the International Arbitration practice’s work advising sovereign states and multinational companies in proceedings before major arbitral institutions. Clients praised the practice’s understanding of the Asian market, noting, “they know the Asian market very well, not only the law, but also the culture and the clients.” The Life Sciences & Healthcare practice was recognized for providing “practical and sophisticated advice across regulatory, transactional, investigations, and disputes matters” and its ability to handle complex cross-border matters through collaboration across jurisdictions and disciplines. Clients also highlighted the team’s “deep understanding of regulatory requirements in both China and the United States,” industry knowledge, and efficient delivery of advice and solutions.

Arnold & Porter has nearly 40 years of experience representing U.S., European, and international companies doing business in China, as well as Chinese companies doing business overseas. The firm represents clients in international commercial and investor-State arbitration across a range of industries. Its life sciences team advises pharmaceutical, biotechnology, medical device, and healthcare companies on regulatory, compliance, and transactional matters, including market access, licensing, clinical trials, anti-corruption, due diligence, and investigations.